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Fully Defined Medium for Organotypic Skin Equivalent Cultures
Skin equivalents mimicking native dermal–epidermal tissue architecture
are wanted as tools for a variety of investigations, such as for mechanistic
studies of skin physiology, for pharmaco-toxicologic testing, for use as
skin substitutes in wound treatment, or for use as models for studying
genotype-phenotype correlations and gene therapy approaches for
hereditary skin diseases. Also, the function of diffusible factors mediating
epithelial–mesenchymal interactions and the dynamics of basement
membrane formation have been studied in equivalents constructed
with keratinocytes and fibroblasts. To provide for optimal growth of
both cell types in the coculture, the skin equivalents have been
maintained in media containing serum or pituitary extract, both of
which contain an unknown mixture of cytokines and other molecules
that may interfere with the biologic phenomena under study. In this
issue, Stark et al (p. 681) report a serum-free, defined medium for
skin equivalents formed by keratinocytes cocultured with fibroblasts
embedded in collagen lattices. The authors demonstrate that a defined
medium (SKDM) supports epidermal morphogenesis in organotypic
cocultures just as well as a serum-containing medium. An orthokeratin-
ized epithelium evolved in both media, but keratin 1 and 10 synthesis
was better coordinated in SKDM medium. The late differentiation
markers filaggrin, involucrin, keratin 2e, and transglutaminase 1 were
In Vivo Gene Therapy with IL-12 Inhibits Vascular Tumor Growth
Localized primary vascular tumors occur in 12% of infants, typically
characterized by an often alarming rate of expansion during the first
6 mo of life. Despite their rapid growth and potential for disfigurement,
these tumors are often not treated because of the side-effects of available
therapy and the tendency of the tumors to involute spontaneously
during the first decade of life. In 5%–10% of patients, the rapid growth
of the vascular tumors results in complications, particularly skin
ulceration, visual and airway obstruction, and heart failure. Thrombocy-
topenia, microangiopathic anemia, and coagulopathy are additional
features of some vascular tumors, and are thought to be related to the
rapid enlargement of the tumor. Despite aggressive intervention with
currently available systemic medications, the bleeding diathesis leads
to drastic complications in a significant number of infants.
Interleukin (IL)-12 has been shown to have both potent immune-
mediated antitumor effects and antiangiogenic effects. These known
actions suggest that IL-12 may be particularly well suited as a therapeutic
agent for treating primary vascular tumors. To test this hypothesis,
Wang et al (p. 755) used a mouse model of Kasabach-Merritt syndrome
and gene transfer of interleukin-12 cDNA into the peritumoral area
of immunocompetent 129/J mice with life-threatening primary vascular
tumors. As systemic administration of recombinant IL-12 protein had
been shown to cause concentration-dependent toxicity in the mouse
and human, and is very costly, gene gun application of interleukin-12
cDNA was chosen for this study. Particle-mediated gene bombardment
is a rapid, painless technique ideal for transient gene expression of
secreted gene products, such as cytokines. The gene in an episomal
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typically expressed in upper suprabasal layers, and keratin 16 persisted,
indicating the activated epidermal state in both culture systems.
Keratinocyte proliferation was comparable in both media, whereas
fibroblast multiplication and proliferation was delayed and reduced in
SKDM. The ultrastructural features of epidermal differentiation and of
basement membrane reconstitution were similar in both media; how-
ever, immature lamellar bodies and cytoplasmatic vacuoles indicated
an impaired lipid metabolism in SKDM.
This study represents a major step towards standardization of the
in vitro systems by eliminating ill-defined medium supplements, such
as serum or organ extracts, which contain many bioactive factors in
highly variable and mostly unknown compositions, which may seriously
interfere with physiologic interactions and may compromise the clinical
application of skin equivalents as grafts. The new defined organotypic
cocultures reported here provide a suitable basis for in vitro skin models
to study molecular mechanisms of tissue homeostasis, and to test the
effects of differentiation modulators, growth, and nutritive factors.
Besides, defined skin equivalents can now be developed for pharmacol-
ogic and toxicologic in vitro testing as an alternative to animal models
and for therapeutic use as skin substitutes for wound coverage or
gene therapy.
vector is coated onto gold beads, and propelled into tissue by helium
pressure. The majority of gene expression after bombardment into
mouse skin was seen in the epidermis, with no detectable IL-12
expression in the underlying tumor tissue using immunohistochemical
and ELISA detection techniques. The application of interleukin-12
cDNA into peritumoral areas reduced tumor volume 7.5-fold and
almost tripled the duration of mouse survival, in contrast with luciferase-
bombarded control mice. Epidermal expression of mouse interleukin-
12 elevated tumoral and serum levels of interferon-γand tumor necrosis
factor-α, increased the tumoral populations of T-lymphocyte and
natural killer cells, and induced tumor apoptosis. The discrepancy
between localization of IL-12 expression and tumor localization suggests
that IL-12 does not act directly on tumor cells, but instead amplifies
the inherent antitumor immune response. In concert with this finding,
gene transfer of interleukin-12 had little effect on tumor volumes
and survival of tumor-bearing athymic nude mice, emphasizing the
requirement for T cell directed cellular immunity.
The authors demonstrated that in vivo gene gun introduction of
mIL-12 prevents the rapid growth of a life-threatening, primary vascular
tumor and increases mouse survival. Peritumoral gene gun introduction
of IL-12 may be a novel, cost-effective approach to limit the growth
and associated mortality of life-threatening human tumors. In studies
with human skin, the penetration of the gold beads is limited to the
epidermis, providing the added advantage that the gold beads are all
shed as epidermal cells mature and are desquamated during the month
after the bombardment.
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Photoaging Affects Microfibrils in the Papillary Dermis
Photoaged skin appears coarse, roughened and deeply wrinkled with
marked loss of elasticity and recoil. By light microscopy, abundant
dystrophic elastotic material immunopositive for tropoelastin and
fibrillin can be found in the reticular dermis. In normal skin, the elastic
fiber network forms a continuum from the dermal–epidermal junction
(DEJ) to the deeper dermis. It comprises thick elastin-rich fibers within
the reticular dermis, a network of finer fibers with reduced elastin in
the lower papillary dermis, and cascades of discrete microfibrillar
bundles, without measurable elastin, in the upper papillary dermis,
terminating at the DEJ. Fibrillin is a product of dermal fibroblasts, but
keratinocytes also express fibrillin and can assemble microfibrils. The
process of elastic fiber formation is under tight developmental control
with tropoelastin deposited upon a preformed microfibrillar template
perinatally and during early development.
In this issue, Watson et al (p. 782) tested the hypothesis that loss of
microfibrillar integrity in the upper dermis contributes to the clinical
appearance and reduced elasticity of photoaged skin. Samples from
photoaged and photoprotected skin of subjects with a clinical range of
photoaging were examined for fibrillin-1 and fibrillin-2 expression and
for the distribution and abundance of fibrillin-rich microfibrils. In situ
hybridization revealed decreased fibrillin-1 mRNA but unchanged
fibrillin-2 mRNA levels in severely photoaged forearm biopsies relative
to photoprotected dermal sites. An immunohistochemical approach
demonstrated a significant reduction of microfibrils at the DEJ, and
Pathogenicity of Pemphigus Autoantibodies
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) both involve
acantholysis and blister formation; however, they are clinically and
histologically distinguishable. PV targets the skin and mucosal epithelia,
and the acantholysis is observed just above the basal cell layer. In
contrast, PF affects only the epidermis, and the acantholysis occurs in
the upper part of the epidermis. The autoantigen for PV is the 130 kDa
desmoglein 3 (Dsg3) and for PF the 160 kDa desmoglein 1 (Dsg1),
both desmosomal glycoproteins of the desmoglein subfamily of the
cadherin protein superfamily. The expression of Dsg1 and Dsg3 in the
epidermis corresponds precisely to the site where blisters appear in PF
and PV, and correspondingly Dsg1-specific autoantibodies recognize
keratinocyte surfaces mainly in the upper epidermis, whereas Dsg3-
specific autoantibodies predominantly react with the basal and suprabasal
layers of the epidermis. The autoantibodies are pathogenic, as deter-
mined by the passive transfer studies in which IgG isolated from sera
of pemphigus patients were injected into neonatal mice and induced
acantholysis with the classic immunohistological features seen in human
patients. Interestingly, over 50% of PV sera recognize both Dsg3 and
Dsg1, whereas PF sera do not cross-react with Dsg3; however, the
pathogenicity of the anti-Dsg1 autoantibodies in PV has remained
unknown. Dsg1 and Dsg3 are 46% identical at the amino acid sequence
level, and it has been speculated that the presence of anti-Dsg1
reactivity in PV sera is due to cross-reactivity of certain anti-Dsg3
antibodies with Dsg1. The alternative is that PV sera contain two
distinct populations of antibodies - one against Dsg1 and the other
against Dsg3.
In order to discriminate between these two possibilities, Ding et al
confocal microscopy revealed that the papillary dermal microfibrillar
network was truncated and depleted in photoaged skin. Examination
of minimally photoaged skin also revealed a marked loss of fibrillin-
positive structures at the DEJ, implying that this molecule is one of
the first constituents of the dermal extracellular matrix to be affected
or damaged by solar irradiation.
An interesting parallel to changes in the microfibrillar network in
photoaged skin is presentation of striae distensae in the skin of patients
with Marfan syndrome, a hereditary disorder caused by mutations in
fibrillin-1 gene. The same authors have recently identified reductions
in the elastic fiber network in striae distensae, where both fibrillin
microfibrils and elastin in the papillary dermis are affected equally. It
therefore seems unlikely that the observed reduction in fibrillin-rich
microfibrils in photoaged skin is due to any spatial confinement brought
about by increased abnormal elastin production and deposition in the
papillary dermis. Rather, microfibril depletion observed as a result of
prolonged, chronic ultraviolet exposure is likely to reflect the action
of inflammatory cell proteinases or matrix metalloproteinases, which
are capable of degrading intact microfibrils.
These studies highlight that the fibrillin-rich microfibrillar network
associated with the upper dermis and the DEJ is susceptible to damage
caused by solar irradiation, probably due to the activity of matrix
degrading enzymes. These data may indicate a novel target for
pharmacologic manipulation of photoaged skin.
(p. 739) studied affinity-purified PV autoantibodies with recombinant
soluble extracellular domains of Dsg1 and Dsg3 expressed in the
baculovirus system, and showed no cross-reactivity between autoanti-
bodies directed against Dsg1 and Dsg3. Subsequently, the extracellular
domains were used to affinity-purify anti-Dsg1 and anti-Dsg3 autoanti-
bodies from PV sera, and the pathogenicity of each fraction was
examined separately using the passive transfer mouse model. The anti-
Dsg1 autoantibodies in PV induced typical PF lesions in neonatal mice,
whereas the anti-Dsg3 fraction induced PV-like lesions. These findings
indicate that the anti-Dsg1 antibodies in PV are pathogenic. Interes-
tingly, the anti-Dsg1 antibodies in PV induced PF-like lesions in
neonatal mice, even though the patients from whom the sera were
drawn had typical PV blisters. The discrepancy between the mouse
model results and clinical observations is most likely due to the
difference in anti-Dsg1 antibody titers in PV patients and in the
injected mice that received a high dose of the purified IgG.
Certain patients transit from PV to PF and this conversion is
associated with a change of autoantibody profiles from predominant
anti-Dsg3 to anti-Dsg1. One interpretation is that the original auto-
immune response is directed against a pathogenic epitope on Dsg3 and
later the response spreads to other epitope(s) that cross-react with
Dsg1. The data, however, suggest an ‘‘intermolecular epitope spreading’’
rather than an ‘‘intramolecular epitope spreading’’ mechanism, since
anti-Dsg1 and anti-Dsg3 antibodies in PV sera are not cross-reactive.
These findings help in dissecting the immunopathogenesis of pemphigus
and in developing more effective therapeutic strategies for human
autoimmune diseases.
